Emilio Hirsch

发表

Phosphoproteomics Identifies PI3K Inhibitor–selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance

E. Hirsch, O. Burlet-Schiltz, M. Reichert, 2020, Molecular Cancer Therapeutics.

Priorities in Cardio-Oncology Basic and Translational Science

A. Ghigo, I. García-Lunar, P. Thavendiranathan, 2023, JACC. CardioOncology.

Linking phosphoinositide function to mitosis.

F. Gulluni, Lorenzo Prever, Emilio Hirsch, 2024, Cell reports.

PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer

P. Cappello, J. Varner, C. Roux, 2024, Journal of experimental & clinical cancer research : CR.